EAM
KYMR icon

Eventide Asset Management’s Kymera Therapeutics KYMR Stock Holding History

Eventide Asset Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.2M Buy
626,925
+495
+0.1% +$39.2K 0.86% 37
2025
Q4 		$48.7M Sell
626,430
-18,160
-3% -$1.23M 0.76% 37
2025
Q3 		$36.5M Buy
644,590
+81,600
+14% +$3.68M 0.6% 65
2025
Q2 		$24.6M Buy
562,990
+37,852
+7% +$1.3M 0.43% 82
2025
Q1 		$14.4M Buy
525,138
+69,410
+15% +$2.53M 0.29% 104
2024
Q4 		$18.3M Sell
455,728
-52,174
-10% -$2.36M 0.33% 96
2024
Q3 		$24M Buy
507,902
+45,803
+10% +$2.02M 0.41% 75
2024
Q2 		$13.8M Buy
462,099
+442,325
+2,237% +$15.3M 0.24% 110
2024
Q1 		$795K Buy
+19,774
New +$708K 0.01% 155

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return